Citations (45)
Keep up to date with the latest research on this topic with citation updates for this article.
Articles from other publishers (45)
Ayse Agac, Sophie M. Kolbe, Martin Ludlow, Albert D. M. E. Osterhaus, Robert Meineke & Guus F. Rimmelzwaan. (2023) Host Responses to Respiratory Syncytial Virus Infection. Viruses 15:10, pages 1999.
Crossref
Crossref
Federica Attaianese, Sara Guiducci, Sandra Trapani, Federica Barbati, Lorenzo Lodi, Giuseppe Indolfi, Chiara Azzari & Silvia Ricci. (2023) Reshaping Our Knowledge: Advancements in Understanding the Immune Response to Human Respiratory Syncytial Virus. Pathogens 12:9, pages 1118.
Crossref
Crossref
Yasemın ARDICOGLU AKIŞIN, Defne TARIM, Mustafa TURAN & Nejat AKAR. (2022) Platelet to Lymphocyte Ratıo in Respıratory Syncytıal Vırus InfectıonRespiratuvar Sinsityal Virüs Enfeksiyonunda Platelet Lenfosit Oranı. Avrasya Sağlık Bilimleri Dergisi 6:1, pages 11-15.
Crossref
Crossref
Qiong Zhang, Si Li & Qiong Huang. (2021) Pratensein glycoside attenuates respiratory syncytial virus infection-induced oxidative and inflammatory injury via TGF-β signaling pathway. Molecular & Cellular Toxicology 18:3, pages 329-337.
Crossref
Crossref
Clyde Dapat, Satoru Kumaki, Hiroki Sakurai, Hidekazu Nishimura, Hannah Karen Mina Labayo, Michiko Okamoto, Mayuko Saito & Hitoshi Oshitani. (2021) Gene signature of children with severe respiratory syncytial virus infection. Pediatric Research 89:7, pages 1664-1672.
Crossref
Crossref
Thomas Démoulins, Melanie Brügger, Beatrice Zumkehr, Blandina I. Oliveira Esteves, Kemal Mehinagic, Amal Fahmi, Loïc Borcard, Adriano Taddeo, Damian Jandrasits, Horst Posthaus, Charaf Benarafa, Nicolas Ruggli & Marco P. Alves. (2021) The specific features of the developing T cell compartment of the neonatal lung are a determinant of respiratory syncytial virus immunopathogenesis. PLOS Pathogens 17:4, pages e1009529.
Crossref
Crossref
Katherine M. Eichinger, Jessica L. Kosanovich, Madeline Lipp, Kerry M. Empey & Nikolai Petrovsky. (2021) Strategies for active and passive pediatric RSV immunization. Therapeutic Advances in Vaccines and Immunotherapy 9, pages 251513552098151.
Crossref
Crossref
Ignacio Esteban, Renato T. Stein & Fernando P. Polack. (2020) A Durable Relationship: Respiratory Syncytial Virus Bronchiolitis and Asthma past Their Golden Anniversary. Vaccines 8:2, pages 201.
Crossref
Crossref
Yashoda Madaiah Hosakote & Kempaiah Rayavara. 2020. Oxidative Stress in Lung Diseases. Oxidative Stress in Lung Diseases
297
330
.
David G. Hancock, Elena C. Cavallaro, Elizabeth Doecke, Molly Reynolds, Billie Charles-Britton, Dani-Louise Dixon & Kevin D. Forsyth. (2019) Immune biomarkers predicting bronchiolitis disease severity: A systematic review. Paediatric Respiratory Reviews 32, pages 82-90.
Crossref
Crossref
Jonatan J. Carvajal, Andrea M. Avellaneda, Camila Salazar-Ardiles, Jorge E. Maya, Alexis M. Kalergis & Margarita K. Lay. (2019) Host Components Contributing to Respiratory Syncytial Virus Pathogenesis. Frontiers in Immunology 10.
Crossref
Crossref
Kiran Aftab Gul, Tonje Sonerud, Hans O. Fjærli, Britt Nakstad, Tore Gunnar Abrahamsen & Christopher S. Inchley. (2017) Thymus activity measured by T-cell receptor excision circles in patients with different severities of respiratory syncytial virus infection. BMC Infectious Diseases 17:1.
Crossref
Crossref
Clark D. Russell, Stefan A. Unger, Marc Walton & Jürgen Schwarze. (2017) The Human Immune Response to Respiratory Syncytial Virus Infection. Clinical Microbiology Reviews 30:2, pages 481-502.
Crossref
Crossref
T. Ronan Leahy, Ross McManus, Derek G. Doherty, Robert Grealy, Michael J. Carr, Dubhfeasa Slattery & Thomas Ryan. (2016) Viral Bronchiolitis is Associated With Altered Cytokine Gene Expression and Lymphocyte Activation Status. Pediatric Infectious Disease Journal 35:11, pages e326-e338.
Crossref
Crossref
Jodi L. McGill & Randy E. Sacco. (2016) γδ T cells and the immune response to respiratory syncytial virus infection. Veterinary Immunology and Immunopathology 181, pages 24-29.
Crossref
Crossref
Kimberly Risma & Rebecca Marsh. 2016. Manual of Molecular and Clinical Laboratory Immunology. Manual of Molecular and Clinical Laboratory Immunology
775
780
.
T. Ronan Leahy, Ross McManus, Derek G. Doherty, Robert Grealy, Tanya Coulter, Paul Smyth, Gordon Blackshields, Orla Sheils, Michael J. Carr, Nikhil Purandare, Michael Geary, Hennie M. Hodemaekers, Riny Janssen, Louis Bont, Dubhfeasa Slattery & Thomas Ryan. (2016) Interleukin-15 is associated with disease severity in viral bronchiolitis. European Respiratory Journal 47:1, pages 212-222.
Crossref
Crossref
Mohamed A. FarragFahad N. Almajhdi. (2016) Human Respiratory Syncytial Virus: Role of Innate Immunity in Clearance and Disease Progression. Viral Immunology 29:1, pages 11-26.
Crossref
Crossref
Dani-Louise Dixon. (2015) The Role of Human Milk Immunomodulators in Protecting Against Viral Bronchiolitis and Development of Chronic Wheezing Illness. Children 2:3, pages 289-304.
Crossref
Crossref
Efrain Guzman & Geraldine Taylor. (2015) Immunology of bovine respiratory syncytial virus in calves. Molecular Immunology 66:1, pages 48-56.
Crossref
Crossref
Chen-Yu Tsai, Ka Hang Liong, Matilda Gertrude Gunalan, Na Li, Daniel Say Liang Lim, Dale A. Fisher, Paul A. MacAry, Yee Sin Leo, Siew-Cheng Wong, Kia Joo Puan & Soon Boon Justin Wong. (2015) Type I IFNs and IL-18 Regulate the Antiviral Response of Primary Human γδ T Cells against Dendritic Cells Infected with Dengue Virus. The Journal of Immunology 194:8, pages 3890-3900.
Crossref
Crossref
Silvia Vandini, Paolo Bottau, Giacomo Faldella & Marcello Lanari. (2015) Immunological, Viral, Environmental, and Individual Factors Modulating Lung Immune Response to Respiratory Syncytial Virus. BioMed Research International 2015, pages 1-7.
Crossref
Crossref
Hanne K. Brand, Gerben Ferwerda, Frank Preijers, Ronald de Groot, Chris Neeleman, Frank J.T. Staal, Adilia Warris & Peter W.M. Hermans. (2012) CD4+ T-cell counts and interleukin-8 and CCL-5 plasma concentrations discriminate disease severity in children with RSV infection. Pediatric Research 73:2, pages 187-193.
Crossref
Crossref
Randy Sacco, Jodi McGill, Mitchell Palmer, John Lippolis, Timothy Reinhardt & Brian Nonnecke. (2012) Neonatal Calf Infection with Respiratory Syncytial Virus: Drawing Parallels to the Disease in Human Infants. Viruses 4:12, pages 3731-3753.
Crossref
Crossref
Matthew T. Lotz & R. Stokes PeeblesJrJr. (2012) Mechanisms of Respiratory Syncytial Virus Modulation of Airway Immune Responses. Current Allergy and Asthma Reports 12:5, pages 380-387.
Crossref
Crossref
Peter Rigaux, Kristin E. Killoran, Zhijun Qiu & Helene F. Rosenberg. (2012) Depletion of alveolar macrophages prolongs survival in response to acute pneumovirus infection. Virology 422:2, pages 338-345.
Crossref
Crossref
Sophia Davidson, Gerard Kaiko, Zhixuan Loh, Amit Lalwani, Vivian Zhang, Kirsten Spann, Shen Yun Foo, Nicole Hansbro, Satoshi Uematsu, Shizuo Akira, Klaus I. Matthaei, Helene F. Rosenberg, Paul S. Foster & Simon Phipps. (2011) Plasmacytoid Dendritic Cells Promote Host Defense against Acute Pneumovirus Infection via the TLR7–MyD88-Dependent Signaling Pathway. The Journal of Immunology 186:10, pages 5938-5948.
Crossref
Crossref
Hiromichi OHTSUKA, Machiko MUKAI, Erika TANAMI, Mayumi TOKITA, Yayoi HASHIBA, Masayuki KOHIRUIMAKI, Ken-ichi SHIBANO, Kiyoshi MIURA & Stephen MORRIS. (2011) Relationship between Diarrhea and Peripheral Leukocyte Population in Neonatal Japanese Black Calves. Journal of Veterinary Medical Science 73:11, pages 1477-1479.
Crossref
Crossref
Gerard E. Kaiko, Simon Phipps, Pornpimon Angkasekwinai, Chen Dong & Paul S. Foster. (2010) NK Cell Deficiency Predisposes to Viral-Induced Th2-Type Allergic Inflammation via Epithelial-Derived IL-25. The Journal of Immunology 185:8, pages 4681-4690.
Crossref
Crossref
Carmen L. Larrañaga, Sandra L. Ampuero, Vivian F. Luchsinger, Flavio A. Carrión, Nelson V. Aguilar, Pamela R. Morales, María Angélica M. Palomino, Lorena F. Tapia & Luis F. Avendaño. (2009) Impaired Immune Response in Severe Human Lower Tract Respiratory Infection by Respiratory Syncytial Virus. Pediatric Infectious Disease Journal 28:10, pages 867-873.
Crossref
Crossref
Young-Mok Lee, Nobuaki Miyahara, Katsuyuki Takeda, John Prpich, Anita Oh, Annette Balhorn, Anthony Joetham, Erwin W. Gelfand & Azzeddine Dakhama. (2008) IFN-γ Production during Initial Infection Determines the Outcome of Reinfection with Respiratory Syncytial Virus. American Journal of Respiratory and Critical Care Medicine 177:2, pages 208-218.
Crossref
Crossref
Jean-Louis VincentM. C. J. Kneyber & F. B. Plötz. 2007. Intensive Care Medicine. Intensive Care Medicine
145
156
.
M. C. J. Kneyber & F. B. Plötz. 2007. Intensive Care Medicine. Intensive Care Medicine
145
156
.
Martin L. Moore & R. Stokes PeeblesJr.Jr.. (2006) Respiratory syncytial virus disease mechanisms implicated by human, animal model, and in vitro data facilitate vaccine strategies and new therapeutics. Pharmacology & Therapeutics 112:2, pages 405-424.
Crossref
Crossref
Stephen P. Brearey & Rosalind L. Smyth. 2006. Respiratory Syncytial Virus. Respiratory Syncytial Virus
141
162
.
Fabrizio Poccia, Chiara Agrati, Federico Martini, Maria Rosaria Capobianchi, Marianne Wallace & Miroslav Malkovsky. (2005) Antiviral reactivities of γδ T cells. Microbes and Infection 7:3, pages 518-528.
Crossref
Crossref
M F E ROE, D M BLOXHAM, D K WHITE, R I ROSS-RUSSELL, R T C TASKER & D R O'DONNELL. (2004) Lymphocyte apoptosis in acute respiratory syncytial virus bronchiolitis. Clinical and Experimental Immunology 137:1, pages 139-145.
Crossref
Crossref
H AYUKAWA, T MATSUBARA, M KANEKO, M HASEGAWA, T ICHIYAMA & S FURUKAWA. (2004) Expression of CTLA-4 (CD152) in peripheral blood T cells of children with influenza virus infection including encephalopathy in comparison with respiratory syncytial virus infection. Clinical and Experimental Immunology 137:1, pages 151-155.
Crossref
Crossref
Inesz J. van Benten, Cornelis M. van Drunen, Laurens P. Koopman, Alex KleinJan, Barbara C. van Middelkoop, Leon de Waal, Albert D.M.E. Osterhaus, Herman J. Neijens & Wytske J. Fokkens. (2003) RSV‐induced bronchiolitis but not upper respiratory tract infection is accompanied by an increased nasal IL‐18 response. Journal of Medical Virology 71:2, pages 290-297.
Crossref
Crossref
Paul S McNamara & Rosalind L Smyth. (2002) The pathogenesis of respiratory syncytial virus disease in childhood. British Medical Bulletin 61:1, pages 13-28.
Crossref
Crossref
M Kroca, A Tärnvik & A Sjöstedt. (2000)
The proportion of circulating
γδ
T cells increases after the first week of onset of tularaemia and remains elevated for more than a year
. Clinical and Experimental Immunology 120:2, pages 280-284.
Crossref
Crossref
A.H. Brandenburg, A. Kleinjan, B. van het Land, H.A. Moll, H.H. Timmerman, R.L. de Swart, H.J. Neijens, W. Fokkens & A.D.M.E. Osterhaus. (2000) Type 1-like immune response is found in children with respiratory syncytial virus infection regardless of clinical severity. Journal of Medical Virology 62:2, pages 267-277.
Crossref
Crossref
S.M. van Schaik, R.C. Welliver & J.L.L. Kimpen. (2000) Novel pathways in the pathogenesis of respiratory syncytial virus disease. Pediatric Pulmonology 30:2, pages 131-138.
Crossref
Crossref
JUDITH H. ABERLE, STEPHAN W. ABERLE, MICHAEL N. DWORZAK, CHRISTIAN W. MANDL, WINFRIED REBHANDL, GEORG VOLLNHOFER, MICHAEL KUNDI & THERESE POPOW-KRAUPP. (1999) Reduced Interferon- γ Expression in Peripheral Blood Mononuclear Cells of Infants with Severe Respiratory Syncytial Virus Disease. American Journal of Respiratory and Critical Care Medicine 160:4, pages 1263-1268.
Crossref
Crossref
Tracy Hussell & Peter Openshaw. (1999) Recent developments in the biology of respiratory syncytial virus: are vaccines and new treatments just round the corner?. Current Opinion in Microbiology 2:4, pages 410-414.
Crossref
Crossref